Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

Neurology. Neuroimmunology and Neuroinflammation
Collin M SpencerScott S Zamvil

Abstract

To evaluate the influence of dimethyl fumarate (DMF, Tecfidera) treatment of multiple sclerosis (MS) on leukocyte and lymphocyte subsets. Peripheral blood leukocyte and lymphocyte subsets, including CD3(+), CD4(+), and CD8(+) T cells; CD19(+) B cells; and CD56(+) natural killer (NK) cells, were obtained at baseline and monitored at 3 months, 6 months, and 12 months after initiation of DMF treatment. Total leukocyte and lymphocyte counts diminished after 6 months of DMF therapy. At 12 months, lymphocyte counts had decreased by 50.1% (p < 0.0001) and were below the lower limit of normal (LLN) in one-half of patients. CD3(+) T lymphocyte counts fell by 44.2% (p < 0.0001). Among subsets, CD8(+) T cell counts declined by 54.6% (p < 0.0001), whereas CD4(+) T cell counts decreased by 39.2% (p = 0.0006). This disproportionate reduction of CD8(+) T cells relative to CD4(+) T cells was significant (p = 0.007) and was reflected by a 35.5% increase in the CD4/CD8 ratio (p = 0.007). A majority of CD8(+) T cell counts, but not CD4(+) T cell counts, were below the LLN even when total lymphocyte counts were greater than 500 cells/μL. CD19(+) B cell counts were reduced by 37.5% (p = 0.035). Eosinophil levels decreased by 54.1% (p = 0.006), wher...Continue Reading

Citations

Dec 19, 2015·Microvascular Research·Jamie L LimJack van Horssen
Jan 19, 2016·Frontiers in Immunology·Rui LiUNKNOWN MSSRF Canadian B cells in MS Team
Jan 21, 2016·The New England Journal of Medicine·Deepak Balak, Enes Hajdarbegovic
Mar 5, 2016·Nature Reviews. Neurology·Alexander WinkelmannUwe K Zettl
Jul 8, 2015·Annals of Neurology·Thorsten BartschIgor J Koralnik
Aug 6, 2015·The New England Journal of Medicine·Dennis J NieuwkampBob W van Oosten
Apr 15, 2016·Proceedings of the National Academy of Sciences of the United States of America·Ulf Schulze-TopphoffScott S Zamvil
Jul 22, 2015·Multiple Sclerosis and Related Disorders·Regina Berkovich, Leslie P Weiner
May 20, 2016·Journal of Neurology·Jonathan ZurawskiJacob A Sloane
Sep 21, 2016·Multiple Sclerosis and Related Disorders·Marie Colombe AgahozoSandra Amor
Aug 16, 2016·Nature Reviews. Neurology·Manoj K Mishra, V Wee Yong
Sep 7, 2016·Expert Opinion on Pharmacotherapy·Nikolaos GrigoriadisGünther F L Hofbauer
Oct 17, 2016·Neurology and Therapy·Sheena L DupuyRohit Bakshi
Nov 10, 2015·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Erin E LongbrakeAnne H Cross
Feb 6, 2017·Autoimmunity Reviews·Courtney S CasserlyLuc Vallières
Apr 25, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Vinzenz FleischerFelix Luessi
Oct 16, 2015·Multiple Sclerosis : Clinical and Laboratory Research·E E LongbrakeL Piccio
Jun 14, 2017·Multiple Sclerosis Journal - Experimental, Translational and Clinical·C ChavesA Camac
Nov 7, 2017·European Journal of Immunology·Matthew D SmithPavan Bhargava
Dec 16, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rui LiAmit Bar-Or
Mar 5, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Qi WuYang Mao-Draayer
Oct 5, 2017·Expert Opinion on Drug Safety·Fabiana AuricchioConcetta Rafaniello
May 10, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Erin E LongbrakeLaura Piccio
Aug 28, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Massimiliano CalabreseSalvatore Monaco
Nov 7, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Maria Antonietta MazzolaRoopali Gandhi
Apr 1, 2018·Experimental Dermatology·Jürgen BrückKamran Ghoreschi
Jan 10, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R ZivadinovB Weinstock-Guttman
Jan 24, 2018·Cold Spring Harbor Perspectives in Medicine·Joseph J SabatinoStephen L Hauser
Jan 27, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·H DickelP Altmeyer
Jun 5, 2019·Continuum : Lifelong Learning in Neurology·Robert H Gross, John R Corboy
Mar 13, 2019·Neurology. Clinical Practice·Edward J FoxAaron Boster
Apr 6, 2017·Neurology. Neuroimmunology and Neuroinflammation·Mahtab GhadiriAmit Bar-Or
Sep 30, 2017·Neurology. Neuroimmunology and Neuroinflammation·Katy WrightDarin T Okuda
Jan 4, 2018·Neurology. Neuroimmunology and Neuroinflammation·Maryam Nakhaei-NejadFabrizio Giuliani
Nov 22, 2017·Neurology. Neuroimmunology and Neuroinflammation·Christian von HehnSarah I Sheikh
Oct 23, 2018·Neurology. Neuroimmunology and Neuroinflammation·Elsebeth Staun-RamAriel Miller

❮ Previous
Next ❯

Software Mentioned

Prism
GraphPad
Fumaderm

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.